Santa Monica, Calif., May 31, 2011–Reprints Desk, Inc., a supplier of journal articles for research and evidence-based promotions, today announced the appointment of Armand Brevig as Global Sales Director with responsibility for customer retention, new customer acquisition, and sales distribution channels. Mr. Brevig will be based in the United Kingdom and report to President and Chief Executive Officer (CEO) Peter Derycz, who previously managed the company’s sales activities and will continue serving as the company’s President and CEO.
"Armand is an expert within the Information Services and Pharmaceutical industries, possessing a keen understanding of customer needs as a result of his unique experiences working in influential positions on both the buyer and supplier side of the business,” said Derycz. “As the company’s first ever Global Sales Director, Armand will have an immediate impact on our global sales capabilities, strategic planning, and innovation, and will be tasked with doubling our sales force.”
Mr. Brevig was most recently the Global (Content Procurement) Category Leader at AstraZeneca, which reported $33.27 billion in 2010 annual revenues. In this position, Mr. Brevig led the creation of the first global Strategic Information Services Sourcing group, led a global multimillion-dollar cross-cultural reprint (scientific journal articles) project, and influenced business process outsourcing (BPO) strategies.
Prior to his most recent position at AstraZeneca, Mr. Brevig was Global Lead (Information) Buyer at AstraZeneca. He has also worked as a Senior Supplier Account Manager (Market Data Acquisition) at Thomson Financial, Supplier Account Manager (Market Data) at Thomson Financial, Programme Officer (Stationed in Zambia) at United Nations Industrial Development Organization, and Acting UNIDO Office Manager (Zambia) at United Nations Industrial Development Organization. Mr. Brevig is fluent in French, German, Danish and English. For more information about Reprints Desk, visit www.reprintsdesk.com.
About Reprints Desk®
Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions and scientific, technical, and medical (STM) research. Organizations based on intellectual property (IP) choose Reprints Desk because of its collaborative business approach, efficient article supply system and services, and commitment to quality post-sales support. Outsell Inc., an independent analyst and advisory firm, ranked Reprints Desk #1 in the most recent Document Delivery Vendor Scorecard.
Forward-Looking Statements
Certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in obtaining new customers; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; the Company’s success in integrating acquired entities and assets, and all the risks and related information described from time to time in the Company's filings with the Securities and Exchange Commission ("SEC"), including the financial statements and related information contained in the Company's Annual Report on Form 10-K. The Company assumes no obligation to update the cautionary information in this release.
Leah Rodriguez | VP of Marketing
Leah has over 17 years of experience in publishing and software with various roles leading and developing marketing teams. Prior to joining Research Solutions, she was at Nature Publishing Group, launching marketing for their open access journals, Nature Communications and Scientific Reports and at PLOS, developing...